Evolution of the Average Target: OrthoPediatrics Corp.

Evolution of the Target Price: OrthoPediatrics Corp.

Changes in Analyst Recommendations: OrthoPediatrics Corp.

be666606c6ace4bdb2c3fcf.VqIO64Xx3e-gxOSaO3-Ge_dw1py1uONN7R3TN6mQxYA.O_tYicG3jYrGr4iqUQm3S8cluNbA65Ubv1OeWN_FjsQY72yP6qeumc-OqQ~f3b46b0818828cf87e17173e7265803b
08-05 Truist Adjusts Price Target on OrthoPediatrics to $22 From $20, Maintains Hold Rating MT
07-16 Truist Securities Adjusts Price Target on OrthoPediatrics to $20 From $17, Maintains Hold Rating MT
03-02 Truist Adjusts Price Target on OrthoPediatrics to $20 From $19, Maintains Hold Rating MT
01-27 TD Cowen Initiates OrthoPediatrics at Buy With $23 Price Target MT
12-10 Canaccord Genuity Initiates OrthoPediatrics at Buy With $24 Price Target MT
29/10/25 Truist Raises Price Target on OrthoPediatrics to $19 From $18, Keeps Hold Rating MT
29/10/25 Needham Cuts Price Target on OrthoPediatrics to $26 From $42, Keeps Buy Rating MT
08/05/25 Truist Securities Adjusts OrthoPediatrics Price Target to $26 From $24, Maintains Hold Rating MT
11/04/25 Truist Cuts Price Target on OrthoPediatrics to $24 From $26, Keeps Hold Rating MT
05/03/25 Truist Securities Adjusts OrthoPediatrics Price Target to $26 From $25, Maintains Hold Rating MT
18/12/24 Truist Securities Adjusts Price Target on OrthoPediatrics to $25 From $28, Keeps Hold Rating MT
14/10/24 Truist Lowers Price Target on OrthoPediatrics to $28 From $34, Keeps Hold Rating MT
13/09/24 Truist Raises Price Target on OrthoPediatrics to $34 From $30, Maintains Hold Rating MT
07/08/24 Truist Adjusts Price Target on OrthoPediatrics to $30 From $35, Maintains Hold Rating MT
16/07/24 Truist Trims Price Target on OrthoPediatrics to $35 From $38, Maintains Hold Rating MT
07/05/24 Truist Securities Raises Price Target on OrthoPediatrics to $38 From $35, Maintains Hold Rating MT
08/03/24 Truist Securities Adjusts Price Target on OrthoPediatrics to $32 From $31, Maintains Hold Rating MT
25/01/24 Truist Securities Downgrades OrthoPediatrics to Hold From Buy, Adjusts Price Target to $31 From $39 MT
22/12/23 Truist Securities Adjusts Price Target on OrthoPediatrics to $39 From $35, Maintains Buy Rating MT
08/11/23 Truist Adjusts Price Target on OrthoPediatrics to $35 From $31, Maintains Buy Rating MT
07/11/23 Needham Cuts OrthoPediatrics' Price Target to $37 From $55, Maintains Buy Rating MT
04/10/23 BTIG Lowers Price Target on OrthoPediatrics to $52 From $59, Keeps Buy Rating MT
02/05/23 Needham Raises OrthoPediatrics' Price Target to $55 From $51, Maintains Buy Rating MT
17/04/23 Truist Securities Adjusts Price Target on OrthoPediatrics to $57 From $53, Keeps Buy Rating MT
31/01/23 Truist Securities Raises Price Target on OrthoPediatrics to $56 From $47, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+8.58%
+16.75%
+18.99%
+6.2%
+47.78%
- - +14.26%
-1.74%
+40.79%
- - -
Average +18.95%
Weighted average by Cap. +16.99%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
24.50USD
Average target price
27.22USD
Spread / Average Target
+11.11%
High Price Target
35.00USD
Spread / Highest target
+42.86%
Low Price Target
22.00USD
Spread / Lowest Target
-10.20%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Truist Securities
TD Cowen
Canaccord Genuity
Needham & Co.
BTIG
Stifel Nicolaus
JMP Securities
Piper Sandler
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
CCC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
9
Last Close Price
24.50USD
Average target price
27.22USD
Spread / Average Target
+11.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KIDS Stock
  4. Consensus OrthoPediatrics Corp.